3
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61427 |
Lamivudine salicylate
|
Others | Others |
Lamivudine (BCH-189) salicylate is an orally active nucleoside reverse transcriptase inhibitor (NRTI) that effectively inhibits the reverse transcriptase activity of both HIV 1/2 and hepatitis B virus. Moreover, it demonstrates the ability to penetrate the central nervous system [1] [2]. | |||
T0682 |
Lamivudine
GR109714X,BCH-189,拉米夫定 |
HIV Protease; Reverse Transcriptase | Microbiology/Virology; Proteases/Proteasome |
Lamivudine (BCH-189) 是一种核苷逆转录酶抑制剂,可抑制HIV 逆转录酶1和2 以及乙型肝炎病毒的逆转录酶。 | |||
T25609 |
Lamivudine, (+/-)-trans-
Lamivudine specified impurity B |
Others | Others |
Lamivudine, (+/-)-trans- is a reverse transcriptase inhibitor and zalcitabine analog. It is used for the treatment of hepatitis B (HBV) and Human Immunodeficiency Virus Type 1 (HIV-1). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMID-0285 |
Lamivudine-13C-d2
|
||
Lamivudine-13C-d2 是 Lamivudine 的 13C 和氘代化合物。Lamivudine 的 CAS 号为 134678-17-4。Lamivudine 是一种核苷逆转录酶抑制剂,可抑制HIV逆转录酶1和2 以及乙型肝炎病毒的逆转录酶。 | |||
T11814 |
Lamivudine 13C,15N2
|
Others | Others |
Lamivudine 13C,15N2, an impurity of Lamivudine (BCH-189), functions as an inhibitor of both HIV-1/2 reverse transcriptase and hepatitis B virus reverse transcriptase, classifying it as a nucleoside reverse transcriptase inhibitor (NRTIs). |